Revenue: Q4 of $3.52 billion vs $3.33 billion; Full year of $13.95 billion vs $13.01 billion Diluted EPS: Q4 of $1.98 vs $1.70; Full year of $10.46 vs $8.84 Adjusted EPS: Q4 of $4.07 vs $3.45; Full ...
Restructuring and other charges represent amounts incurred in connection with the elimination of redundant positions and facilities and contract termination costs within the organization in connection ...
Labcorp delivered mixed third-quarter results, with higher sales and raised profit guidance but a lower full-year revenue forecast as it “takes action” on an underperforming unit. First, overall sales ...
(1) 2025 Updated guidance includes an impact from foreign currency translation of 0.4%. (2) Enterprise level revenue is presented net of intersegment transaction eliminations. (3) 2025 Updated ...
Restructuring and other charges represent amounts incurred in connection with the elimination of redundant positions and facilities and contract termination costs within the organization in connection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results